M. Skrinjar

Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration.

S. Connolly, M. Skrinjar, A. Rosendahl, 2012, Biochemical pharmacology.

Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites.

Didier Rognan, Chris de Graaf, Steve Price, 2009, Journal of medicinal chemistry.

Small molecule antagonists of CCR8 inhibit eosinophil and T cell migration.

S. Connolly, M. Skrinjar, A. Rosendahl, 2011, Biochemical and biophysical research communications.

Chirospecific synthesis of trans-2,5-disubstituted pyrrolidines via stereoselective addition of organocopper reagents to N-acyliminium ions.

M. Skrinjar, L. Wistrand, 1991 .

An efficient synthesis of (+)-anatoxin-a

M. Skrinjar, L. Wistrand, C. Nilsson, 1992 .

Highly stereoselective addition of alkylcopper reagents to n-acyliminium ions. Enantioselective synthesis of trans-2-butyl-5-heptylpyrrolidine

M. Skrinjar, L. Wistrand, 1990 .

Evaluation of Watson-like integrals for a hyper bcc antiferromagnetic lattice

M. Pantić, D. Kapor, S. Radošević, 2010, 1003.1853.

Critical properties of an S=1 multispin coupling Ising model

F. Iglói, D. Kapor, M. Skrinjar, 1987 .

Small molecule antagonists of CCR8 inhibit eosinophil and T cell migration.

S. Connolly, M. Skrinjar, A. Rosendahl, 2011, Biochemical and biophysical research communications.